{"cik":"0002114044","ticker":"COAG","name":"Hemab Therapeutics Holdings, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-04-27","last_filing_date":"2026-08-11","url":"/sec/cik-0002114044","insider_summary":{"total_transactions":40,"unique_insiders":4,"latest_transaction":"2026-06-16"},"recent_filings":[{"accession_number":"0001193125-26-401010","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-24","title":"8-K — Hemab Therapeutics Holdings, Inc. — 2026-09-24","url_slug":"/sec/cik-0002114044/8-k/0001193125-26-401010","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-401010-index.html"},{"accession_number":"0001193125-26-343421","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — Hemab Therapeutics Holdings, Inc. — 2026-08-11","url_slug":"/sec/cik-0002114044/8-k/0001193125-26-343421","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-343421-index.html"},{"accession_number":"0001193125-26-344533","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-11","title":"10-Q — Hemab Therapeutics Holdings, Inc. — 2026-08-11","url_slug":"/sec/cik-0002114044/10-q/0001193125-26-344533","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-344533-index.html"},{"accession_number":"0000315066-26-002021","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-08-06","title":"SCHEDULE 13G — Hemab Therapeutics Holdings, Inc. — 2026-08-06","url_slug":"/sec/cik-0002114044/schedule-13g/0000315066-26-002021","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0000315066-26-002021-index.html"},{"accession_number":"0001193125-26-233375","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-21","title":"8-K — Hemab Therapeutics Holdings, Inc. — 2026-05-21","url_slug":"/sec/cik-0002114044/8-k/0001193125-26-233375","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-233375-index.html"},{"accession_number":"0001193125-26-234386","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-21","title":"10-Q — Hemab Therapeutics Holdings, Inc. — 2026-05-21","url_slug":"/sec/cik-0002114044/10-q/0001193125-26-234386","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-234386-index.html"},{"accession_number":"0001193125-26-178809","form_type":"S-1/A","form_type_family":"registration","doc_date":"2026-04-27","title":"S-1/A — Hemab Therapeutics Holdings, Inc. — 2026-04-27","url_slug":"/sec/cik-0002114044/s-1-a/0001193125-26-178809","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-178809-index.html"},{"accession_number":"0001193125-26-181893","form_type":"8-A12B","form_type_family":"other","doc_date":"2026-04-27","title":"8-A12B — Hemab Therapeutics Holdings, Inc. — 2026-04-27","url_slug":"/sec/cik-0002114044/8-a12b/0001193125-26-181893","edgar_url":"https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-181893-index.html"}],"related_endpoints":{"profile":"/sec/COAG/profile","timeline":"/sec/COAG/timeline","peers":"/sec/COAG/peers","insider_pulse":"/sec/COAG/insider-pulse","insider_summary":"/sec/COAG/insider-summary","insider_transactions":"/sec/COAG/insider-transactions","form144":"/sec/COAG/form144","holdings_as_filer":"/sec/COAG/holdings","financial_facts":"/sec/COAG/financial-facts","derivatives":"/sec/COAG/derivatives","officers":"/sec/COAG/officers","insider_network":"/sec/COAG/insider-network","risk_flags":"/sec/COAG/risk-flags","filings":"/sec/COAG/filings","cross_topic_dossier":"/api/v1/dossier?ticker=COAG"}}